Physician profile
Janine L Cooper
NPI 1669413134
$2,305.07
in general payments reported to CMS, 2019-2025
17 companies · $758 in 2025
The $758 reported for 2025 was more than what 86% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $250 · 2022: $547 · 2023: $187 · 2024: $563 · 2025: $758.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,508.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,507.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $402.25 | 2024-2025 | Atriclip Laa Exclusion System, Synergy Ablation System, Atricure Cryoice Cryoablation System (Cryo2) |
| Amgen INC. | $217.75 | 2022-2025 | Repatha |
| Edwards Lifesciences Corporation | $204.37 | 2024 | |
| Medtronic, INC. | $155.75 | 2022 | |
| Abiomed | $151.93 | 2025 | |
| Penumbra, INC. | $150.00 | 2022 | |
| Bolton Medical INC | $147.81 | 2022 | |
| Elutia, INC. | $141.94 | 2021 | |
| Abbott Laboratories | $131.72 | 2024 | Thoratec Heartmate 3 Lvas Implant Kit |
| Becton, Dickinson and Company | $130.68 | 2025 | Hemosphere |
| Baxter Healthcare | $108.44 | 2021 | |
| Chiesi USA, INC. | $104.50 | 2023 | Cleviprex |
| Revance Therapeutics, INC. | $93.75 | 2024 | Daxxify |
| Solventum Corporation | $81.97 | 2025 | Activ.A.C. |
| Janssen Pharmaceuticals, INC | $30.52 | 2023 | Xarelto |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $28.34 | 2023 | Gore Tag Thoracic Branch Endoprosthesis |
| Astrazeneca Pharmaceuticals LP | $23.35 | 2023 | Farxiga |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janine Cooper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.